IFI6 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P09912 |
---|---|
Clone Names | 100324139 |
Peptide ID | 100324139 |
Gene ID | 2537 |
---|---|
Other Names | Interferon alpha-inducible protein 6, Interferon-induced protein 6-16, Ifi-6-16, IFI6, G1P3 |
Format | Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | IFI6 (HGNC:4054) |
---|---|
Function | Plays a role in apoptosis, negatively regulating the intrinsinc apoptotic signaling pathway and TNFSF10-induced apoptosis (PubMed:15685448, PubMed:17823654, PubMed:26244642). However, it has also been shown to have a pro-apoptotic activity (PubMed:27673746). Has an antiviral activity towards hepatitis C virus/HCV by inhibiting the EGFR signaling pathway, which activation is required for entry of the virus into cells (PubMed:25757571). |
Cellular Location | Mitochondrion inner membrane; Multi-pass membrane protein |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene was first identified as one of the many genesinduced by interferon. The encoded protein may play a critical rolein the regulation of apoptosis. A minisatellite that consists of 26repeats of a 12 nucleotide repeating element resembling themammalian splice donor consensus sequence begins near the end ofthe second exon. Alternatively spliced transcript variants thatencode different isoforms by using the two downstream repeat unitsas splice donor sites have been described.
References
Davila, S., et al. Genes Immun. 11(3):232-238(2010)Szegedi, K., et al. Exp. Dermatol. 19(3):269-278(2010)Johnatty, S.E., et al. PLoS Genet. 6 (7), E1001016 (2010) :Zhao, D., et al. Virol. J. 5, 114 (2008) :Cheriyath, V., et al. J. Clin. Invest. 117(10):3107-3117(2007)

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.

Request Quote Here